DOCS (Doximity, Inc.) Stock Analysis - Insider Trades

Doximity, Inc. (DOCS) is a publicly traded Healthcare sector company. As of May 20, 2026, DOCS trades at $19.65 with a market cap of $3.62B and a P/E ratio of 15.59. DOCS moved +3.30% today. Year to date, DOCS is -56.53%; over the trailing twelve months it is -62.53%. Its 52-week range spans $17.15 to $85.21. Analyst consensus is buy with an average price target of $26.78. Rallies surfaces DOCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading DOCS stock inside the company?

Recent DOCS insider activity includes Sitaram Siddharth sold 2.31K, Wampler Kira Scherer sold 9.00K, Sitaram Siddharth sold 2.43K, Sitaram Siddharth sold 2.32K, and Wampler Kira Scherer sold 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

DOCS Key Metrics

Key financial metrics for DOCS
MetricValue
Price$19.65
Market Cap$3.62B
P/E Ratio15.59
EPS$1.27
Dividend Yield0.00%
52-Week High$85.21
52-Week Low$17.15
Volume3.63M
Avg Volume0
Revenue (TTM)$637.78M
Net Income$239.40M
Gross Margin89.75%

Recent DOCS Insider Trades

  • Sitaram Siddharth sold 2.31K (~$59.50K) on May 11, 2026.
  • Wampler Kira Scherer sold 9.00K (~$234.54K) on May 7, 2026.
  • Sitaram Siddharth sold 2.43K (~$51.19K) on Apr 10, 2026.
  • Sitaram Siddharth sold 2.32K (~$58.83K) on Mar 10, 2026.
  • Wampler Kira Scherer sold 2.00K (~$52.00K) on Mar 3, 2026.

Latest DOCS News

DOCS Analyst Consensus

21 analysts cover DOCS: 0 strong buy, 9 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.78.

Common questions about DOCS

Who is trading DOCS stock inside the company?
Recent DOCS insider activity includes Sitaram Siddharth sold 2.31K, Wampler Kira Scherer sold 9.00K, Sitaram Siddharth sold 2.43K, Sitaram Siddharth sold 2.32K, and Wampler Kira Scherer sold 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for DOCS?
Yes. Rallies tracks DOCS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is DOCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DOCS. It does not provide personalized investment advice.
DOCS

DOCS